Javascript must be enabled to continue!
PIP MRI Magnetization Transfer Ratio (MTR) Measurement of Myelofibrosis in Mouse Tibia v2
View through CrossRef
The goal of this Co-Clinical Imaging Research Program (CIRP) pre-clinical imaging protocol (PIP) is to provide detailed description of key steps used to achieve a stated level of technical repeatability (precision) embodied in “Claims”, for MRI measurement of magnetization transfer ratio (MTR) in tibia bone marrow of myelofibrosis mouse models. This pre-clinical imaging procedure document will be referred to as a “profile” and adheres to a PIP MRI template provided in: https://www.protocols.io/workspaces/pre-clinical-imaging-protocols. Here we treat MTR as a “quantitative” metric, although numerical MTR results are a strong function of multiple experimental parameters and MRI hardware conditions. This profile will adopt the common practice to express MTR values in on a 0 to 1 scale. Empirically, MTR reflects fraction of visible signal loss due to application of off-resonance saturation RF energy depleting magnetization in the semi-solid (invisible) macromolecular matrix thus reducing magnetization replenishing visible signal.Simple fluids free of macromolecules should have an MTR » 0, whereas macromolecule-rich semi-solid tissues such as myelin, muscle, scar and collagen exhibit relatively high MTR (> 0.5). This document details procedures for MTR measurement in MF mouse tibia to achieve stated performance claims. Tibia bone marrow composition in MF mouse models has gradation going from proximal to distil ends of the tibia, therefore separate claims are made for volume of interest (VOI) analysis of MTR maps for each of three distinct sections along the length of the tibia (see Figure 1): Section 1 (proximal)º VOI (~4-5mm3) within 9mm of proximal end of tibia Section 2 (transition)º VOI (~0.4-0.5mm3) from 10 to 12mm of proximal end of tibia Section 3 (distil)º VOI (~0.1-0.2mm3) from 13 to 14mm of proximal end of tibia Claim 1:A measured change in the mean MTR in Section 1 VOI of MF mouse model tibia that exceeds ±0.16 indicates a true biological change has occurred in the tibia bone marrow with 95% confidence. Claim 2:A measured change in the mean MTR in Section 2 VOI of MF mouse model tibia that exceeds ±0.11 indicates a true biological change has occurred in the tibia bone marrow with 95% confidence. Claim 3:A measured change in the mean MTR in Section 3 VOI of MF mouse model tibia that exceeds ±0.09 indicates a true biological change has occurred in the tibia bone marrow with 95% confidence.
Title: PIP MRI Magnetization Transfer Ratio (MTR) Measurement of Myelofibrosis in Mouse Tibia v2
Description:
The goal of this Co-Clinical Imaging Research Program (CIRP) pre-clinical imaging protocol (PIP) is to provide detailed description of key steps used to achieve a stated level of technical repeatability (precision) embodied in “Claims”, for MRI measurement of magnetization transfer ratio (MTR) in tibia bone marrow of myelofibrosis mouse models.
This pre-clinical imaging procedure document will be referred to as a “profile” and adheres to a PIP MRI template provided in: https://www.
protocols.
io/workspaces/pre-clinical-imaging-protocols.
Here we treat MTR as a “quantitative” metric, although numerical MTR results are a strong function of multiple experimental parameters and MRI hardware conditions.
This profile will adopt the common practice to express MTR values in on a 0 to 1 scale.
Empirically, MTR reflects fraction of visible signal loss due to application of off-resonance saturation RF energy depleting magnetization in the semi-solid (invisible) macromolecular matrix thus reducing magnetization replenishing visible signal.
Simple fluids free of macromolecules should have an MTR » 0, whereas macromolecule-rich semi-solid tissues such as myelin, muscle, scar and collagen exhibit relatively high MTR (> 0.
5).
This document details procedures for MTR measurement in MF mouse tibia to achieve stated performance claims.
Tibia bone marrow composition in MF mouse models has gradation going from proximal to distil ends of the tibia, therefore separate claims are made for volume of interest (VOI) analysis of MTR maps for each of three distinct sections along the length of the tibia (see Figure 1): Section 1 (proximal)º VOI (~4-5mm3) within 9mm of proximal end of tibia Section 2 (transition)º VOI (~0.
4-0.
5mm3) from 10 to 12mm of proximal end of tibia Section 3 (distil)º VOI (~0.
1-0.
2mm3) from 13 to 14mm of proximal end of tibia Claim 1:A measured change in the mean MTR in Section 1 VOI of MF mouse model tibia that exceeds ±0.
16 indicates a true biological change has occurred in the tibia bone marrow with 95% confidence.
Claim 2:A measured change in the mean MTR in Section 2 VOI of MF mouse model tibia that exceeds ±0.
11 indicates a true biological change has occurred in the tibia bone marrow with 95% confidence.
Claim 3:A measured change in the mean MTR in Section 3 VOI of MF mouse model tibia that exceeds ±0.
09 indicates a true biological change has occurred in the tibia bone marrow with 95% confidence.
Related Results
Hydatid Disease of The Brain Parenchyma: A Systematic Review
Hydatid Disease of The Brain Parenchyma: A Systematic Review
Abstarct
Introduction
Isolated brain hydatid disease (BHD) is an extremely rare form of echinococcosis. A prompt and timely diagnosis is a crucial step in disease management. This ...
PIP MRI Magnetization Transfer Ratio (MTR) Measurement of Myelofibrosis in Mouse Tibia v1
PIP MRI Magnetization Transfer Ratio (MTR) Measurement of Myelofibrosis in Mouse Tibia v1
The goal of this Co-Clinical Imaging Research Program (CIRP) pre-clinical imaging protocol (PIP) is to provide detailed description of key steps used to achieve a stated level of t...
Apparent Diffusion Coefficient Measurement of Myelofibrosis in Mouse Tibia v1
Apparent Diffusion Coefficient Measurement of Myelofibrosis in Mouse Tibia v1
The goal of this Co-Clinical Imaging Research Program (CIRP) pre-clinical imaging protocol (PIP) is to provide detailed description of key steps used to achieve a stated level of t...
Thyroid Hormones Maintain The CTCL Malignant Phenotype Through Membrane- and Nuclear-Initiated Transcriptional Programs
Thyroid Hormones Maintain The CTCL Malignant Phenotype Through Membrane- and Nuclear-Initiated Transcriptional Programs
Abstract
Cutaneous T-cell lymphomas (CTCL) are a heterogeneous group of T-cell non-Hodgkin lymphomas (T-NHL) derived from skin-homing mature T cells. Thyroid hormone...
Novel treatment of intracerebral hemorrhage with mechanical tissue resuscitation
Novel treatment of intracerebral hemorrhage with mechanical tissue resuscitation
OBJECTIVE
The previous laboratory and clinical experience of the authors had demonstrated that application of controlled subatmospheric pressure directly to injured soft tissue can...
Could rituximab be a silver lining in refractory bone marrow fibrosis caused by lupus?
Could rituximab be a silver lining in refractory bone marrow fibrosis caused by lupus?
Systemic lupus erythematosus (SLE) is a systemic autoimmune disease that can present with a variety of clinical manifestations, ranging from mild skin involvement to multisystemic ...
Program Indonesia Pintar: Implementasi Kebijakan Jaminan Sosial Bidang Pendidikan
Program Indonesia Pintar: Implementasi Kebijakan Jaminan Sosial Bidang Pendidikan
Smart Indonesia Program (PIP) is one of social security policies in education with a purpose to provide assistance for students from underprivileged families. What raise as a probl...
Proton Density Fat Fraction (PDFF) Measurement of Myelofibrosis in Mouse Tibia v1
Proton Density Fat Fraction (PDFF) Measurement of Myelofibrosis in Mouse Tibia v1
This document details procedures for PDFF measurement in MF mouse tibia to achieve stated performance claims.In this profile PDFF values are expressed in “% units” on a 0 to 100% s...

